Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.

A prospective randomized study was conducted to determine the efficacy of imipenem-cilastatin (hereafter referred to as imipenem) (500 mg four times daily) versus combination therapy for febrile neutropenic patients receiving either no prophylaxis or ciprofloxacin for prevention of infections. Combi...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Cornelissen, J J, de Graeff, A, Verdonck, L F, Branger, T, Rozenberg-Arska, M, Verhoef, J, Dekker, A W
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1992
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189424/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1503442/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.801
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!